10-Q Filing

CARDINAL HEALTH INC CIK: 721371 Q3 2023

Filing Information

Form Type	10-Q
Accession Number	`0001628280-23-015775`
Period End Date	20230331
Filing Date	20230504
Fiscal Year	2023
Fiscal Period	Q3
XBRL Instance	cah-20230331_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 72 Income Statement 92 Cash Flow Statement 74 Stockholders Equity 62 Comprehensive Income 28

Balance Sheet 72 line items

Line Item	Tag	Value	Unit	Period
Preferred shares, authorized	`PreferredStockSharesAuthorized`	500,000.00	shares	Point-in-time
Preferred shares, authorized	`PreferredStockSharesAuthorized`	500,000.00	shares	Point-in-time
Preferred shares, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred shares, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.99B	USD	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.72B	USD	Point-in-time
Common shares, authorized	`CommonStockSharesAuthorized`	755.00M	shares	Point-in-time
Common shares, authorized	`CommonStockSharesAuthorized`	755.00M	shares	Point-in-time
Common shares, issued	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Trade receivables, net	`ReceivablesNetCurrent`	$10.99B	USD	Point-in-time
Trade receivables, net	`ReceivablesNetCurrent`	$10.56B	USD	Point-in-time
Common shares, issued	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Common shares in treasury	`TreasuryStockCommonShares`	54.00M	shares	Point-in-time
Common shares in treasury	`TreasuryStockCommonShares`	72.00M	shares	Point-in-time
Inventories, net	`InventoryNet`	$15.64B	USD	Point-in-time
Inventories, net	`InventoryNet`	$16.62B	USD	Point-in-time
Prepaid expenses and other	`OtherAssetsCurrent`	$1.90B	USD	Point-in-time
Prepaid expenses and other	`OtherAssetsCurrent`	$2.02B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$32.94B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$33.50B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.36B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.36B	USD	Point-in-time
Goodwill and other intangibles, net	`IntangibleAssetsNetIncludingGoodwill`	$6.57B	USD	Point-in-time
Goodwill and other intangibles, net	`IntangibleAssetsNetIncludingGoodwill`	$7.63B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$951.00M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$953.00M	USD	Point-in-time
Total assets	`Assets`	$43.88B	USD	Point-in-time
Total assets	`Assets`	$43.38B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$27.13B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$29.60B	USD	Point-in-time
Current portion of long-term obligations and other short-term borrowings	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$26.00M	USD	Point-in-time
Current portion of long-term obligations and other short-term borrowings	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$580.00M	USD	Point-in-time
Other accrued liabilities	`OtherAccruedLiabilitiesCurrent`	$2.88B	USD	Point-in-time
Other accrued liabilities	`OtherAccruedLiabilitiesCurrent`	$2.84B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$30.55B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$32.50B	USD	Point-in-time
Long-term obligations, less current portion	`LongTermDebtAndCapitalLeaseObligations`	$4.74B	USD	Point-in-time
Long-term obligations, less current portion	`LongTermDebtAndCapitalLeaseObligations`	$4.71B	USD	Point-in-time
Deferred income taxes and other liabilities	`DeferredTaxAndOtherLiabilitiesNoncurrent`	$9.30B	USD	Point-in-time
Deferred income taxes and other liabilities	`DeferredTaxAndOtherLiabilitiesNoncurrent`	$8.38B	USD	Point-in-time
Authorized500 thousand shares, Issuednone	`PreferredStockValue`	-	USD	Point-in-time
Authorized500 thousand shares, Issuednone	`PreferredStockValue`	-	USD	Point-in-time
Authorized755 million shares, Issued327 million shares at March 31, 2023 and June 30, 2022	`CommonStockValue`	$2.82B	USD	Point-in-time
Authorized755 million shares, Issued327 million shares at March 31, 2023 and June 30, 2022	`CommonStockValue`	$2.81B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-280.00M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-342.00M	USD	Point-in-time
Common shares in treasury, at cost: 72 million shares and 54 million shares at March 31, 2023 and June 30, 2022, respectively	`TreasuryStockValue`	$3.13B	USD	Point-in-time
Common shares in treasury, at cost: 72 million shares and 54 million shares at March 31, 2023 and June 30, 2022, respectively	`TreasuryStockValue`	$4.55B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-114.00M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-142.00M	USD	Point-in-time
Total Cardinal Health, Inc. shareholders' deficit	`StockholdersEquity`	$-709.00M	USD	Point-in-time
Total Cardinal Health, Inc. shareholders' deficit	`StockholdersEquity`	$-2.22B	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$3.00M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$2.00M	USD	Point-in-time
Total shareholders deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.00B	USD	Point-in-time
Total shareholders deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.22B	USD	Point-in-time
Total shareholders deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-693.00M	USD	Point-in-time
Total shareholders deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.21B	USD	Point-in-time
Total shareholders deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.79B	USD	Point-in-time
Total shareholders deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-706.00M	USD	Point-in-time
Total liabilities and shareholders deficit	`LiabilitiesAndStockholdersEquity`	$43.38B	USD	Point-in-time
Total liabilities and shareholders deficit	`LiabilitiesAndStockholdersEquity`	$43.88B	USD	Point-in-time
Preferred shares, authorized	`PreferredStockSharesAuthorized`	500,000.00	shares	Point-in-time
Preferred shares, authorized	`PreferredStockSharesAuthorized`	500,000.00	shares	Point-in-time
Preferred shares, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred shares, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Common shares, authorized	`CommonStockSharesAuthorized`	755.00M	shares	Point-in-time
Common shares, authorized	`CommonStockSharesAuthorized`	755.00M	shares	Point-in-time
Common shares, issued	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Common shares, issued	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Common shares in treasury	`TreasuryStockCommonShares`	54.00M	shares	Point-in-time
Common shares in treasury	`TreasuryStockCommonShares`	72.00M	shares	Point-in-time

Income Statement 92 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	$44.84B	USD	1 Quarter
Revenue	`Revenues`	$151.56B	USD	3 Qtrs
Revenue	`Revenues`	$134.26B	USD	3 Qtrs
Revenue	`Revenues`	$50.49B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$146.50B	USD	3 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$43.15B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$129.32B	USD	3 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$48.70B	USD	1 Quarter
Gross margin	`GrossProfit`	$4.94B	USD	3 Qtrs
Gross margin	`GrossProfit`	$1.78B	USD	1 Quarter
Gross margin	`GrossProfit`	$1.68B	USD	1 Quarter
Gross margin	`GrossProfit`	$5.06B	USD	3 Qtrs
Distribution, selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$3.40B	USD	3 Qtrs
Distribution, selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$1.18B	USD	1 Quarter
Distribution, selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$1.14B	USD	1 Quarter
Distribution, selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$3.57B	USD	3 Qtrs
Restructuring and employee severance	`RestructuringCharges`	$31.00M	USD	1 Quarter
Restructuring and employee severance	`RestructuringCharges`	$56.00M	USD	3 Qtrs
Restructuring and employee severance	`RestructuringCharges`	$62.00M	USD	3 Qtrs
Restructuring and employee severance	`RestructuringCharges`	$16.00M	USD	1 Quarter
Amortization and other acquisition-related costs	`Amortizationandotheracquisitionrelatedcosts`	$237.00M	USD	3 Qtrs
Amortization and other acquisition-related costs	`Amortizationandotheracquisitionrelatedcosts`	$79.00M	USD	1 Quarter
Amortization and other acquisition-related costs	`Amortizationandotheracquisitionrelatedcosts`	$216.00M	USD	3 Qtrs
Amortization and other acquisition-related costs	`Amortizationandotheracquisitionrelatedcosts`	$74.00M	USD	1 Quarter
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-20.00M	USD	1 Quarter
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-883.00M	USD	3 Qtrs
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-471.00M	USD	1 Quarter
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-1.76B	USD	3 Qtrs
Litigation (recoveries)/charges, net	`GainLossRelatedToLitigationSettlement`	$-61.00M	USD	1 Quarter
Litigation (recoveries)/charges, net	`GainLossRelatedToLitigationSettlement`	$76.00M	USD	1 Quarter
Litigation (recoveries)/charges, net	`GainLossRelatedToLitigationSettlement`	$256.00M	USD	3 Qtrs
Litigation (recoveries)/charges, net	`GainLossRelatedToLitigationSettlement`	$-113.00M	USD	3 Qtrs
Operating earnings/(loss)	`OperatingIncomeLoss`	$-97.00M	USD	1 Quarter
Operating earnings/(loss)	`OperatingIncomeLoss`	$572.00M	USD	1 Quarter
Operating earnings/(loss)	`OperatingIncomeLoss`	$590.00M	USD	3 Qtrs
Operating earnings/(loss)	`OperatingIncomeLoss`	$-632.00M	USD	3 Qtrs
Other (income)/expense, net	`OtherNonoperatingIncomeExpense`	$14.00M	USD	3 Qtrs
Other (income)/expense, net	`OtherNonoperatingIncomeExpense`	$5.00M	USD	3 Qtrs
Other (income)/expense, net	`OtherNonoperatingIncomeExpense`	$-3.00M	USD	1 Quarter
Other (income)/expense, net	`OtherNonoperatingIncomeExpense`	-	USD	1 Quarter
Interest expense, net	`InterestExpense`	$115.00M	USD	3 Qtrs
Interest expense, net	`InterestExpense`	$28.00M	USD	1 Quarter
Interest expense, net	`InterestExpense`	$38.00M	USD	1 Quarter
Interest expense, net	`InterestExpense`	$78.00M	USD	3 Qtrs
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	3 Qtrs
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-10.00M	USD	3 Qtrs
(Gain)/loss on sale of equity interest in naviHealth	`GainLossOnSaleOfInvestments`	-	USD	3 Qtrs
(Gain)/loss on sale of equity interest in naviHealth	`GainLossOnSaleOfInvestments`	$1.00M	USD	1 Quarter
(Gain)/loss on sale of equity interest in naviHealth	`GainLossOnSaleOfInvestments`	-	USD	1 Quarter
(Gain)/loss on sale of equity interest in naviHealth	`GainLossOnSaleOfInvestments`	$2.00M	USD	3 Qtrs
Earnings/(loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$517.00M	USD	3 Qtrs
Earnings/(loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$544.00M	USD	1 Quarter
Earnings/(loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-137.00M	USD	1 Quarter
Earnings/(loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-741.00M	USD	3 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$189.00M	USD	3 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$197.00M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$328.00M	USD	3 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$1.25B	USD	1 Quarter
Net earnings/(loss)	`ProfitLoss`	$328.00M	USD	3 Qtrs
Net earnings/(loss)	`ProfitLoss`	$347.00M	USD	1 Quarter
Net earnings/(loss)	`ProfitLoss`	$-1.07B	USD	3 Qtrs
Net earnings/(loss)	`ProfitLoss`	$-1.39B	USD	1 Quarter
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$3.00M	USD	3 Qtrs
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$2.00M	USD	3 Qtrs
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$2.00M	USD	1 Quarter
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	1 Quarter
Net earnings/(loss) attributable to Cardinal Health, Inc.	`NetIncomeLoss`	$345.00M	USD	1 Quarter
Net earnings/(loss) attributable to Cardinal Health, Inc.	`NetIncomeLoss`	$-1.07B	USD	3 Qtrs
Net earnings/(loss) attributable to Cardinal Health, Inc.	`NetIncomeLoss`	$325.00M	USD	3 Qtrs
Net earnings/(loss) attributable to Cardinal Health, Inc.	`NetIncomeLoss`	$-1.39B	USD	1 Quarter
Basic (in shares)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-5.05	USD	1 Quarter
Basic (in shares)	`IncomeLossFromContinuingOperationsPerBasicShare`	$1.35	USD	1 Quarter
Basic (in shares)	`IncomeLossFromContinuingOperationsPerBasicShare`	$1.24	USD	3 Qtrs
Basic (in shares)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-3.82	USD	3 Qtrs
Diluted (in shares)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$1.34	USD	1 Quarter
Diluted (in shares)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-5.05	USD	1 Quarter
Diluted (in shares)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$1.23	USD	3 Qtrs
Diluted (in shares)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-3.82	USD	3 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	275.00M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	281.00M	shares	3 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	256.00M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	263.00M	shares	3 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	258.00M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	264.00M	shares	3 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	275.00M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	281.00M	shares	3 Qtrs
Cash dividends declared per common share	`CommonStockDividendsPerShareDeclared`	$1.47	USD	3 Qtrs
Cash dividends declared per common share	`CommonStockDividendsPerShareDeclared`	$0.49	USD	1 Quarter
Cash dividends declared per common share	`CommonStockDividendsPerShareDeclared`	$1.49	USD	3 Qtrs
Cash dividends declared per common share	`CommonStockDividendsPerShareDeclared`	$0.50	USD	1 Quarter

Cash Flow Statement 74 line items

Line Item	Tag	Value	Unit	Period
Net earnings/(loss)	`ProfitLoss`	$328.00M	USD	3 Qtrs
Net earnings/(loss)	`ProfitLoss`	$347.00M	USD	1 Quarter
Net earnings/(loss)	`ProfitLoss`	$-1.07B	USD	3 Qtrs
Net earnings/(loss)	`ProfitLoss`	$-1.39B	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$513.00M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$516.00M	USD	3 Qtrs
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-20.00M	USD	1 Quarter
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-883.00M	USD	3 Qtrs
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-471.00M	USD	1 Quarter
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-1.76B	USD	3 Qtrs
Impairments and loss on sale of other investments	`GainLossOnSaleOfOtherInvestments`	-	USD	3 Qtrs
Impairments and loss on sale of other investments	`GainLossOnSaleOfOtherInvestments`	$-3.00M	USD	3 Qtrs
(Gain)/loss on sale of equity interest in naviHealth	`GainLossOnSaleOfInvestments`	-	USD	3 Qtrs
(Gain)/loss on sale of equity interest in naviHealth	`GainLossOnSaleOfInvestments`	$1.00M	USD	1 Quarter
(Gain)/loss on sale of equity interest in naviHealth	`GainLossOnSaleOfInvestments`	-	USD	1 Quarter
(Gain)/loss on sale of equity interest in naviHealth	`GainLossOnSaleOfInvestments`	$2.00M	USD	3 Qtrs
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	3 Qtrs
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-10.00M	USD	3 Qtrs
Share-based compensation	`ShareBasedCompensation`	$65.00M	USD	3 Qtrs
Share-based compensation	`ShareBasedCompensation`	$69.00M	USD	3 Qtrs
Provision for bad debts	`ProvisionForDoubtfulAccounts`	$46.00M	USD	3 Qtrs
Provision for bad debts	`ProvisionForDoubtfulAccounts`	$79.00M	USD	3 Qtrs
Increase in trade receivables	`IncreaseDecreaseInReceivables`	$510.00M	USD	3 Qtrs
Increase in trade receivables	`IncreaseDecreaseInReceivables`	$1.19B	USD	3 Qtrs
Increase in inventories	`IncreaseDecreaseInInventories`	$922.00M	USD	3 Qtrs
Increase in inventories	`IncreaseDecreaseInInventories`	$1.01B	USD	3 Qtrs
Increase in accounts payable	`IncreaseDecreaseInAccountsPayable`	$2.47B	USD	3 Qtrs
Increase in accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.12B	USD	3 Qtrs
Other accrued liabilities and operating items, net	`IncreaseDecreaseInOtherOperatingCapitalNet`	$845.00M	USD	3 Qtrs
Other accrued liabilities and operating items, net	`IncreaseDecreaseInOtherOperatingCapitalNet`	$206.00M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.98B	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$130.00M	USD	3 Qtrs
Proceeds from divestitures, net of cash sold	`ProceedsFromDivestitureOfBusinesses`	-	USD	3 Qtrs
Proceeds from divestitures, net of cash sold	`ProceedsFromDivestitureOfBusinesses`	$923.00M	USD	3 Qtrs
Acquisition of subsidiaries, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$10.00M	USD	3 Qtrs
Acquisition of subsidiaries, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	3 Qtrs
Additions to property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$264.00M	USD	3 Qtrs
Additions to property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$223.00M	USD	3 Qtrs
Proceeds from disposal of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$11.00M	USD	3 Qtrs
Proceeds from disposal of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$2.00M	USD	3 Qtrs
Purchases of investments	`Purchaseofavailableforsalesecuritiesandotherinvestments`	$38.00M	USD	3 Qtrs
Purchases of investments	`Purchaseofavailableforsalesecuritiesandotherinvestments`	$6.00M	USD	3 Qtrs
Proceeds from investments	`Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments`	$1.00M	USD	3 Qtrs
Proceeds from investments	`Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments`	$27.00M	USD	3 Qtrs
Proceeds from net investment hedge terminations	`ProceedsFromHedgeInvestingActivities`	$71.00M	USD	3 Qtrs
Proceeds from net investment hedge terminations	`ProceedsFromHedgeInvestingActivities`	$29.00M	USD	3 Qtrs
Net cash provided by/(used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$771.00M	USD	3 Qtrs
Net cash provided by/(used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-248.00M	USD	3 Qtrs
Reduction of long-term obligations	`RepaymentsOfLongTermDebt`	$571.00M	USD	3 Qtrs
Reduction of long-term obligations	`RepaymentsOfLongTermDebt`	$597.00M	USD	3 Qtrs
Net tax proceeds/(withholdings) from share-based compensation	`Netproceedstaxwithholdingsfromsharebasedcompensation`	$11.00M	USD	3 Qtrs
Net tax proceeds/(withholdings) from share-based compensation	`Netproceedstaxwithholdingsfromsharebasedcompensation`	$-26.00M	USD	3 Qtrs
Dividends on common shares	`PaymentsOfDividendsCommonStock`	$425.00M	USD	3 Qtrs
Dividends on common shares	`PaymentsOfDividendsCommonStock`	$399.00M	USD	3 Qtrs
Purchase of treasury shares	`PaymentsForRepurchaseOfCommonStock`	$1.50B	USD	3 Qtrs
Purchase of treasury shares	`PaymentsForRepurchaseOfCommonStock`	$1.00B	USD	3 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-2.46B	USD	3 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-2.05B	USD	3 Qtrs
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-1.00M	USD	3 Qtrs
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-13.00M	USD	3 Qtrs
Cash and equivalents reclassified from/(to) assets held for sale	`CashReclassifiedToAssetHeldForSale`	-	USD	3 Qtrs
Cash and equivalents reclassified from/(to) assets held for sale	`CashReclassifiedToAssetHeldForSale`	$109.00M	USD	3 Qtrs
Net decrease in cash and equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-727.00M	USD	3 Qtrs
Net decrease in cash and equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-1.05B	USD	3 Qtrs
Cash and equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.72B	USD	Point-in-time
Cash and equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.41B	USD	Point-in-time
Cash and equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.99B	USD	Point-in-time
Cash and equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.36B	USD	Point-in-time
Cash and equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.72B	USD	Point-in-time
Cash and equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.41B	USD	Point-in-time
Cash and equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.99B	USD	Point-in-time
Cash and equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.36B	USD	Point-in-time

Stockholders Equity 62 line items

Line Item	Tag	Value	Unit	Period
Balance at beginning of period (in shares)	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Balance at beginning of period (in shares)	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.00B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.22B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-693.00M	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.21B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.79B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-706.00M	USD	Point-in-time
Treasury, balance at beginning of period (in shares)	`TreasuryStockCommonShares`	54.00M	shares	Point-in-time
Treasury, balance at beginning of period (in shares)	`TreasuryStockCommonShares`	72.00M	shares	Point-in-time
Treasury, balance at beginning of period	`TreasuryStockValue`	$3.13B	USD	Point-in-time
Treasury, balance at beginning of period	`TreasuryStockValue`	$4.55B	USD	Point-in-time
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	`ProfitLoss`	$328.00M	USD	3 Qtrs
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	`ProfitLoss`	$347.00M	USD	1 Quarter
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	`ProfitLoss`	$-1.07B	USD	3 Qtrs
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	`ProfitLoss`	$-1.39B	USD	1 Quarter
Net Income (Loss) Attributable to Parent	`NetIncomeLoss`	$345.00M	USD	1 Quarter
Net Income (Loss) Attributable to Parent	`NetIncomeLoss`	$-1.07B	USD	3 Qtrs
Net Income (Loss) Attributable to Parent	`NetIncomeLoss`	$325.00M	USD	3 Qtrs
Net Income (Loss) Attributable to Parent	`NetIncomeLoss`	$-1.39B	USD	1 Quarter
Other Comprehensive Income (Loss), Net of Tax	`OtherComprehensiveIncomeLossNetOfTax`	$-28.00M	USD	3 Qtrs
Other Comprehensive Income (Loss), Net of Tax	`OtherComprehensiveIncomeLossNetOfTax`	$-43.00M	USD	3 Qtrs
Other Comprehensive Income (Loss), Net of Tax	`OtherComprehensiveIncomeLossNetOfTax`	$4.00M	USD	1 Quarter
Other Comprehensive Income (Loss), Net of Tax	`OtherComprehensiveIncomeLossNetOfTax`	$8.00M	USD	1 Quarter
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$8.00M	USD	1 Quarter
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-43.00M	USD	3 Qtrs
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$4.00M	USD	1 Quarter
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-28.00M	USD	3 Qtrs
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture	`StockIssuedDuringPeriodSharesShareBasedCompensation`	2.00M	shares	3 Qtrs
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	`StockIssuedDuringPeriodValueShareBasedCompensation`	$41.00M	USD	3 Qtrs
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	`StockIssuedDuringPeriodValueShareBasedCompensation`	$24.00M	USD	1 Quarter
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	`StockIssuedDuringPeriodValueShareBasedCompensation`	$82.00M	USD	3 Qtrs
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	`StockIssuedDuringPeriodValueShareBasedCompensation`	$23.00M	USD	1 Quarter
Purchase of treasury shares	`PaymentsForRepurchaseOfCommonStock`	$1.50B	USD	3 Qtrs
Purchase of treasury shares	`PaymentsForRepurchaseOfCommonStock`	$1.00B	USD	3 Qtrs
Dividends	`Dividends`	$128.00M	USD	1 Quarter
Dividends	`Dividends`	$135.00M	USD	1 Quarter
Dividends	`Dividends`	$415.00M	USD	3 Qtrs
Dividends	`Dividends`	$388.00M	USD	3 Qtrs
Other	`StockholdersEquityOther`	$-1.00M	USD	1 Quarter
Other	`StockholdersEquityOther`	-	USD	1 Quarter
Other	`StockholdersEquityOther`	$-1.00M	USD	3 Qtrs
Other	`StockholdersEquityOther`	$-1.00M	USD	3 Qtrs
Balance at end of period (in shares)	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Balance at end of period (in shares)	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.00B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.22B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-693.00M	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.21B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.79B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-706.00M	USD	Point-in-time
Treasury, balance at end of period (in shares)	`TreasuryStockCommonShares`	54.00M	shares	Point-in-time
Treasury, balance at end of period (in shares)	`TreasuryStockCommonShares`	72.00M	shares	Point-in-time
Treasury, balance at end of period	`TreasuryStockValue`	$3.13B	USD	Point-in-time
Treasury, balance at end of period	`TreasuryStockValue`	$4.55B	USD	Point-in-time
Treasury Stock, Value, Acquired, Cost Method	`TreasuryStockValueAcquiredCostMethod`	$1.50B	USD	3 Qtrs
Treasury Stock, Value, Acquired, Cost Method	`TreasuryStockValueAcquiredCostMethod`	$200.00M	USD	1 Quarter
Treasury Stock, Value, Acquired, Cost Method	`TreasuryStockValueAcquiredCostMethod`	$253.00M	USD	1 Quarter
Treasury Stock, Value, Acquired, Cost Method	`TreasuryStockValueAcquiredCostMethod`	$1.00B	USD	3 Qtrs
Treasury shares acquired, average price per share (in usd per share)	`MinorityInterestDecreaseFromRedemptions`	$-2.00M	USD	3 Qtrs
Common shares in treasury	`TreasuryStockCommonShares`	54.00M	shares	Point-in-time
Common shares in treasury	`TreasuryStockCommonShares`	72.00M	shares	Point-in-time

Comprehensive Income 28 line items

Line Item	Tag	Value	Unit	Period
Net earnings/(loss)	`ProfitLoss`	$328.00M	USD	3 Qtrs
Net earnings/(loss)	`ProfitLoss`	$347.00M	USD	1 Quarter
Net earnings/(loss)	`ProfitLoss`	$-1.07B	USD	3 Qtrs
Net earnings/(loss)	`ProfitLoss`	$-1.39B	USD	1 Quarter
Foreign currency translation adjustments and other	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-4.00M	USD	1 Quarter
Foreign currency translation adjustments and other	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$4.00M	USD	1 Quarter
Foreign currency translation adjustments and other	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-47.00M	USD	3 Qtrs
Foreign currency translation adjustments and other	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-34.00M	USD	3 Qtrs
Net unrealized gain on derivative instruments, net of tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$12.00M	USD	1 Quarter
Net unrealized gain on derivative instruments, net of tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$4.00M	USD	3 Qtrs
Net unrealized gain on derivative instruments, net of tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$6.00M	USD	3 Qtrs
Net unrealized gain on derivative instruments, net of tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	-	USD	1 Quarter
Total other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-28.00M	USD	3 Qtrs
Total other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-43.00M	USD	3 Qtrs
Total other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$4.00M	USD	1 Quarter
Total other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$8.00M	USD	1 Quarter
Total comprehensive income/(loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$300.00M	USD	3 Qtrs
Total comprehensive income/(loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-1.11B	USD	3 Qtrs
Total comprehensive income/(loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-1.38B	USD	1 Quarter
Total comprehensive income/(loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$351.00M	USD	1 Quarter
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$3.00M	USD	3 Qtrs
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$2.00M	USD	3 Qtrs
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$2.00M	USD	1 Quarter
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	1 Quarter
Total comprehensive income attributable to Cardinal Health, Inc.	`ComprehensiveIncomeNetOfTax`	$349.00M	USD	1 Quarter
Total comprehensive income attributable to Cardinal Health, Inc.	`ComprehensiveIncomeNetOfTax`	$-1.11B	USD	3 Qtrs
Total comprehensive income attributable to Cardinal Health, Inc.	`ComprehensiveIncomeNetOfTax`	$297.00M	USD	3 Qtrs
Total comprehensive income attributable to Cardinal Health, Inc.	`ComprehensiveIncomeNetOfTax`	$-1.38B	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.